Corrigendum to “In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: Development of interpretive criteria for testing by broth microdilution and disk diffusion” (J. Dairy Sci. 97:6594–6607)

Abstract

Andrew J. Bradley (Quality Milk Management Services Ltd., Somerset, United Kingdom; and University of Nottingham, School of Veterinary Medicine and Science, Sutton Bonington, United Kingdom) was erroneously omitted as a co-author of this article. All authors agree to his addition as an author. The authors regret the error. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: Development of interpretive criteria for testing by broth microdilution and disk diffusionJournal of Dairy ScienceVol. 97Issue 10PreviewDry cow therapy is an important part of mastitis control. This therapy typically consists of an antibiotic or antibiotics administered at a single dose by intramammary infusion at dry off to treat or prevent infection by prevalent mastitis pathogens. A combination dry cow therapy consisting of the active components penicillin and framycetin is currently used in several countries. Despite its use, standardized methods for the susceptibility testing of this combination against mastitis pathogens have not been established. Full-Text PDF Open Archive